Log in to save to my catalogue

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in...

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2012918515

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study

About this item

Full title

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2018-03, Vol.40 (3), p.415-429.e6

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

AbstractPurposeAdalimumab (ADA) is a tumor necrosis factor-α inhibitor indicated for use in various immune-mediated inflammatory diseases. Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care's Patient Support Program (PSP), which provides personalized services, including tailored interventions in the form of nurse-provided ca...

Alternative Titles

Full title

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2012918515

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2012918515

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2018.02.001

How to access this item